Your browser doesn't support javascript.
loading
A Descriptive Review and Meta-Regression Study of Demographic and Study Context Factors in US Clinical Trials of Cognitive Behavioral Interventions for Alcohol or Other Drug Use.
Burnett, Don-Pierre; Trikalinos, Thomas A; Kiluk, Brian D; Ray, Lara; Misquith, Chelsea; Magill, Molly.
Afiliación
  • Burnett DP; School of Public Health, Brown University, Providence, Rhode Island, USA.
  • Trikalinos TA; School of Public Health, Brown University, Providence, Rhode Island, USA.
  • Kiluk BD; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.
  • Ray L; Department of Psychology, University of California at Los Angeles, Los Angeles, California, USA.
  • Misquith C; School of Public Health, Brown University, Providence, Rhode Island, USA.
  • Magill M; University Library, Brown University, Providence RI.
Subst Use Misuse ; : 1-11, 2024 Jun 30.
Article en En | MEDLINE | ID: mdl-38946162
ABSTRACT
Objectives. Cognitive-Behaviorally Based Interventions (CBIs) are evidence-based treatments for alcohol and other drug (AOD) use with potential variable effectiveness by population sub-groups. This study used evidence synthesis to examine treatment effect by demographic and study context factors in clinical trials of CBI for AOD. Methods. Studies were systematically identified, and their characteristics and outcome data were extracted and summarized. Standardized mean differences were calculated for within- and between-condition effects on substance use outcomes. Demographic and study context moderators were identified during data acquisition and several sensitivity analyses were conducted. Results. The sample included K = 29 trials and a total of 15 study-level moderators were examined. Information on participants' age, biological sex, and race were reported in at least 26 trials, but information on gender identity, sexual orientation, and ethnicity were reported infrequently or in non-inclusive ways. The mean between-condition effect size was small and moderately heterogenous (d = 0.158, 95% CI = 0.079, 0.238, I2 = 46%) and the mean within-condition effect size was large and showed high heterogeneity (dz = 1.147, 95% CI = 0.811, 1.482, - I2 = 96%). The specific drug targeted in the study and whether biological assay-based outcomes were used moderated between-condition CBI efficacy and the inclusion of co-occurring mental health conditions and study publication date moderated within-condition CBI effects. Conclusions. Results provide preliminary data on study context factors associated with effect estimates in United States based clinical trials of CBI for AOD.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Subst Use Misuse Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Subst Use Misuse Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos